Patents by Inventor Cara HAYMAKER

Cara HAYMAKER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12637511
    Abstract: Provided herein are methods for the activation and expansion of genetically-modified Tcells, such as tumor infiltrating lymphocytes. In some cases, cells of the embodiments can be used for the therapeutic treatment of human diseases, such as cancer.
    Type: Grant
    Filed: February 16, 2021
    Date of Patent: May 26, 2026
    Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Marie-Andrée Forget, Chantale Bernatchez, Cara Haymaker, Michael A Curran, Patrick Hwu, Cassian Yee
  • Publication number: 20230106973
    Abstract: Provided herein are methods for the activation and expansion of genetically-modified Tcells, such as tumor infiltrating lymphocytes. In some cases, cells of the embodiments can be used for the therapeutic treatment of human diseases, such as cancer.
    Type: Application
    Filed: February 16, 2021
    Publication date: April 6, 2023
    Applicant: Board of Regents, The University of Texas System
    Inventors: Marie-Andrée FORGET, Chantale BERNATCHEZ, Cara HAYMAKER, Michael A. CURRAN, Patrick HWU, Cassian YEE
  • Publication number: 20210340544
    Abstract: The present disclosure relates to methods for treating cancer in patients having low expression of MHC Class I genes, and in patients having increased serum levels of PD-L2 by administration of a TLR9 agonist.
    Type: Application
    Filed: October 18, 2019
    Publication date: November 4, 2021
    Applicant: IDERA PHARMACEUTICALS, INC.
    Inventors: Cara HAYMAKER, Chantale BERNATCHEZ, Adi DIAB, Srinivas CHUNDURU